canada semaglutide patent Ozempic's problem: how Novo Nordisk lost control of a blockbuster drug. 💉 Demand for GLP-1 weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Semaglutide patent expiry opens door

and lipohypertrophy (fatty deposits that develop under the skin), taking semaglutide (the drug in Ozempic) for eight months seemed to slow participants biological aging, according to blood tests that measure age-related biomarkers

GLP-1 is one of two incretin peptide hormones released by the gut upon ingestion of food

Exploring oxidative modifications of tyrosine: an update on mechanisms of formation, advances in analysis and biological consequences

Important Lab Tests for GLP-1 Users People who are starting GLP-1 therapy or are already taking GLP-1 medications (such as semaglutide, liraglutide, dulaglutide) need regular health monitoring

Where to apply: Dr

Patients should be advised to seek immediate medical attention if they experience severe, persistent abdominal pain